We are pleased to announce that our DeepChek® Assay 13-Plex KB Drug Susceptibility Testing, intended to be used for Tuberculosis Drug Resistance assessment through NGS sequencing, is now CE-IVD marked !
DeepChek® Assay 13-Plex KB Drug Susceptibility Testing is now CE-IVD marked
Jun 06, 2022